Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

INSPIRE MEDICAL SYSTEMS, INC.

(INSP)
  Report
Delayed Nyse  -  01:00 2022-11-25 pm EST
230.28 USD   +1.33%
11/16Inspire Medical Systems, Inc. to Present at the Piper Sandler 34th Annual Healthcare Conference
AQ
11/02Inspire Medical Systems, Inc. to Present at the Stifel 2022 Healthcare Conference
AQ
11/01Transcript : Inspire Medical Systems, Inc., Q3 2022 Earnings Call, Nov 01, 2022
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Business Summary
Logo Inspire Medical Systems, Inc.
Inspire Medical Systems, Inc. is a medical technology company. The Company is focused on the development and commercialization of invasive solutions for patients with obstructive sleep apnea (OSA). The obstructive sleep apnea device that treats the root cause of sleep apnea by working inside the body with the patient’s natural breathing process. The Company has developed a novel, closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The Company sells its system to the hospitals and ambulatory surgery centers (ASCs) in the United States and in select countries in Europe through a direct sales organization.

Number of employees : 485 people.
Sales per Business
20202021Delta
Neurostimulation Technology115.38100%233.39100% +102.28%
USD in Million
Sales per region
20202021Delta
United States106.1192%220.9894.7% +108.26%
All Other Countries9.278%12.425.3% +33.92%
USD in Million
Managers
Name Title Age Since
Timothy Herbert President, Chief Executive Officer & Director 58 -
Richard Buchholz Chief Financial Officer 53 2014
Philip Ebeling Chief Operating Officer 50 2020
Bryan Phillips Secretary, Chief Compliance Officer & Senior VP 49 -
Ezgi Yagci Vice President-Investor Relations - 2022
Martin Abrams Vice President-Marketing & Customer Experience - 2019
Ivan Lubogo Senior Vice President-US Sales - 2019
Randall A. Ban Chief Commercial Officer 56 -
John Rondoni VP-Product Development, Operations & Quality - -
Kathy Sherwood Senior Vice President-Global Market Access - -
Members of the board
Name Title Age Since
Marilyn Nelson Chairman 81 2016
Dana George Mead Independent Director 62 2008
Jerry C. Griffin, Dr. Independent Director 76 2008
Casey M. Tansey Independent Director 63 2008
Shawn T. McCormick Independent Director 56 2017
Gary Lee Ellis Independent Director 65 2019
Georgia Garinois-Melenikiotou Independent Director 63 2020
Shelley G. Broader Independent Director 56 2020
Charisse Y. Sparks, Dr. Independent Director 58 2022
Cynthia Burks Independent Director 55 2022
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 28,892,388 28,329,313 98.1% 0 0.0% 98.1%
Shareholders
NameEquities%
The Vanguard Group, Inc. 2,899,902 10.1%
Macquarie Investment Management Business Trust 1,539,475 5.38%
Fidelity Management & Research Co. LLC 1,430,901 5.00%
Franklin Advisers, Inc. 1,092,482 3.81%
Champlain Investment Partners LLC 698,585 2.44%
BlackRock Fund Advisors 683,788 2.39%
Invesco Advisers, Inc. 640,748 2.24%
Wasatch Advisors, Inc. 618,420 2.16%
Gilder, Gagnon, Howe & Co. LLC 605,381 2.11%
Viking Global Investors LP 595,193 2.08%
Company contact information
Inspire Medical Systems, Inc.
5500 Wayzata Boulevard
Suite 1600
Golden Valley, MN 55416

Phone : +1.844.672.4357
Web : http://www.inspiresleep.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Inspire Medical Systems, Inc.